Element Capital Management LLC Bristol Myers Squibb CO Transaction History

Element Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $6 Million - $6.7 Million	-103,578 Reduced 37.33%	173,924 $10.1 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $940,423 - $1.04 Million	14,761 Added 5.62%	277,502 $17.7 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $17.3 Million - $19.6 Million	262,741 New	262,741 $18.2 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $943,624 - $1.04 Million	12,994 Added 50.0%	38,981 $3 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $1.6 Million - $1.92 Million	25,987 New	25,987 $1.9 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $203,589 - $225,603	-3,545 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $194,336 - $227,199	3,545 New	3,545 $208,000
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $3.32 Million - $4.33 Million	-67,519 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $2.89 Million - $3.42 Million	67,519 New	67,519 $3.42 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $5.94 Million - $6.57 Million	-133,171 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $927,937 - $1.11 Million	-20,566 Reduced 13.38%	133,171 $6.35 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $653,871 - $847,914	-13,410 Reduced 8.02%	153,737 $7.99 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $8.86 Million - $9.99 Million	160,453 Added 2396.97%	167,147 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $338,247 - $421,588	6,694 New	6,694 $370,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.